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Abstract
The conception of the Human Microbiome Project advanced the understanding of
microbial communities in the human body and previous research has established that unique
microbial signatures can help distinguish each body fluid. While these signatures have been
developed for the prokaryotic microbiome, the next step is the examination of the eukaryotic
microbiome. Eukaryotic signatures could provide a greater specificity and statistical weight
when discerning between body fluids. These microbial markers can be implemented to develop a
confirmatory assay for body fluid identification that works in tandem with other DNA based
methods in the forensic workflow. Using a VCU approved IRB protocol, samples of urine
(n=100), feces (n=72), and saliva (n=77) were collected. DNA was isolated and quantified using
Qiagen’s QIAamp DNA Investigator and DNA Micro kits. The V9 region of the 18S rDNA was
amplified using dual-index strategy and samples were sequenced on the Illumina MiSeq FGx.
The sequences were analysed using Mothur (v 1.39.5) and RStudio (v 3.6.3). The relative
abundance of eukaryote taxa and an Analysis of Molecular Variance (AMOVA) indicated
significant differences in the eukaryotic community structure between all body fluids, except
male and female urine. At the family level, feces was characterized by the combined presence of
Saccharomycetaceae (80.1%). Malasseziaceae (37.4% male, 36.6% female) and Diptera (22.6%
male, 19.4% female) were indicators for urine, while Poales (43.3%) and Asparagales (10.3%)
indicated saliva. The species richness was greater in urine but less in feces and saliva when
compared to the species richness of the prokaryotic microbiome. Overall, these results indicate
that each body fluid has a unique eukaryotic community and potential for use in body fluid
identification, especially as a compliment to the bacterial signatures that have already been
developed. The results of this study are a novel addition to previous work, and advance the use
of microbial forensics as an alternative method in forensic serology.
Keywords: forensic science, microbiome, 18S rDNA, eukaryote, signature, body fluid
identification, serology, next generation sequencing
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Introduction
The human microbiome, a complex community of microbial organisms consisting of
bacteria, archaea, and eukaryotes, has come to the forefront of medical research in recent years
due to the wealth of information that can be gained from studying what thrives in and on our
bodies (1, 2). The Human Microbiome Project (HMP), formed in 2007, has furthered the
understanding of how the host and the microbes interact and has characterized at least a portion
of the communities that make up the microbiome (3). However, the HMP focuses more on the
biomedical and physiological applications, rather than how it can be utilized for forensic
purposes. Most of the research performed so far has been done with bacteria, by far the most
prevalent microorganism in the human host, by targeting the 16S ribosomal RNA (rRNA) gene.
Because of the difference in the relative abundance of bacteria versus eukaryotes within the
microbiome, there have been fewer studies in the characterization of the eukaryotic communities
using the 18S rRNA gene (4).
Overview of Forensic Serology
Forensic serology is the identification, classification, and study of body fluids as they
relate to a crime. Identifying the body fluid found on evidence is a crucial part of a forensic
investigation, as it guides a forensic analyst to the proper course of action for the evidence
sample. Early scientific methods of blood identification date back to the late 1800’s, starting with
an enzyme test that gave a reaction based on the peroxidase-like activity of hemoglobin (5).
Body fluid identification usually begins with a screening to find areas of interest on larger pieces
of evidence, typically with a chemical indicator or an alternate light source. A presumptive test is
then performed that determines the likelihood that the substance is a particular fluid. Presumptive
tests are subject to false positives because they rely on chemical reactions that occur in multiple
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fluids or naturally in other substances (6). Finally, if one is available, a confirmatory test can be
performed to positively identify a specific body fluid. True confirmatory tests are only available
for blood, using either the Takayama crystal test or an antibody test, and semen, by microscopic
identification or detection of the prostate specific antigen (PSA) (6). The current serological
methods are rapid and low-cost, but are also non-specific and labor intensive. The current tests
for saliva, urine and feces are all presumptive and employed in only about half of laboratories
worldwide, according to a survey done by Desroches et. al. (2009) (6). As DNA analysis systems
and technology have increased in sensitivity, the detection levels for serological techniques of
most fluids have remained unchanged.
New Methodologies for Serological Identification
Due to the nature of current serological methods, more research is being conducted in
alternative methods of body fluid identification that work in tandem with DNA analysis. Several
studies have been done on the use of messenger RNA (mRNA) profiling, where body fluids are
identified by the gene expression of the cell types that comprise the specific fluid (7, 8).
Messenger RNA profiling employs the use of reverse-transcription polymerase chain reaction
(RT-PCR) for detection and is designed to multiplex with capillary electrophoresis (CE) systems
(7). Another, similar technique is the expression of microRNAs (miRNAs), which are small
sections of non-coding RNA, to identify body fluids. In multiple studies, miRNAs have been
shown to be differentially expressed in forensically relevant body fluids (9)(10)(11). Subsequent
studies have developed methods to incorporate this technique using RT-PCR and CE systems to
generate miRNA expression data specific to each body fluid (12). Both of these methods do have
some disadvantages. Messenger RNAs are more prone to degradation because of their longer
sequences compared to miRNAs and miRNA quantitation has been proven to vary depending on
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the method of detection (13). Until recently, the use of the human microbiome for body fluid
identification has remained unexplored.
Microbial Characterization of Body Fluids
Ribosomal RNA genes are sequences of DNA which code for the RNA strands that
comprise sections of the subunits in ribosomes. Because ribosomes are needed to manufacture
proteins and can be found in all cells, the rRNA genes can be sequenced to determine an
organism’s taxonomic group (14). Next-generation sequencing of rRNA genes, specifically the
16S subunit in bacteria and the 18S subunit in eukaryotes, is the current and most reliable
method for phylogenetic classification of the microbiome (15). The samples are each tagged with
a different barcoded primer, amplified through PCR, and parallel sequenced. The sequenced
strands are separated by barcode and compared to reference sequences in SILVA, a database
comprised of aligned rRNA sequences from all three domains: Bacteria, Archaea, and Eukarya
(15). Since the need for further research into the eukaryotic taxa became apparent, the
development of universal primers for 18S rRNA genes has been a priority. Studies done by both
Hadziavdic et. al. (2014) and Wang et. al. (2014) identified the most suitable and effective
primers for use in microbial classification among eukaryotic groups (16, 17). In a study by
Amaral-Zettler et. al., the V9 hypervariable region of the eukaryotic rRNA gene was targeted for
amplification in order to study Protista diversity in ecologically distinct bodies of water (18). The
V9 hypervariable region is used as a target because it is highly conserved among eukaryotes and
there are substantial resources for reference comparison (1).
Mammalian Blocking Primers
Specific primers that anneal to common eukaryotic sequences are used to amplify the V9
hypervariable region (1). In addition to these primers, a mammalian blocking primer is used to
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obstruct the amplification of the host (i.e. vertebrate) DNA by blocking either the annealing or
elongation step during the PCR process. Annealing blockers compete with the normal primers
for binding space while elongation blockers bind between amplification sites and prevent
elongation. The elongation arrest primers have an additional C3 spacer on the 3’ end which
inhibits elongation during amplification. The blocking primers have species-specific sequences
to ensure that only the unwanted mammalian DNA is blocked (19). These blocking primers can
greatly reduce the quantity of human DNA that gets amplified; however they cannot completely
eliminate amplification of the host sequences.
Eukaryotic Taxonomy
Taxonomy, which is the classification of the diversity of organisms, is the foundation on
which biological knowledge is structured. Traditionally, taxonomy has been based on
morphological diversity, but given the complexity of the eukaryotic domain there has been a
shift from the classic four kingdoms proposed by Robert Whittaker in 1969 to a new system of
six supergroups (20). While the bacterial classification database still has its own issues, it
continues to outperform the eukaryotic classification database in terms of accurately identifying
taxa, simply because bacteria have been more extensively studied by the scientific community.
The most commonly used reference file for eukaryotic classification, SILVA NR v132,
relies on a six-level system (Level 1 to Level 6), which corresponds to the classifications
traditionally used at the Domain through Genus levels. This reference uses the UniEuk
taxonomic framework for eukaryote sequence alignment and classification. UniEuk is an opensource, universal taxonomic framework that incorporates the collective current findings of the
research community (21). As with most databases of its kind, it is not a complete and still
produces unclassified sequences. Given the current classification structure of eukaryotic
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taxonomy, it is important to note that analysis of sequences with classification at the genus level
is not as successful as that of the higher taxonomic levels.
Summary of Previous Work
Because of the diversity and abundance of prokaryotes within the human microbiome and
the well-established use of 16S rRNA genes for sequencing, the majority of researchers seeking
to identify body fluids by their microbial signature have focused on the domain Bacteria.
Specifically for forensic application, one study developed a bacterial signature for saliva by
cross-validation against skin samples (22). Work done by Dobay et. al. (2019) determined that
forensically relevant body fluids still retained their unique bacterial composition even after
environmental exposure (23). Data analysis for 16S rDNA sequencing has been optimized to
improve recognition of four different fluid types: oral, nasal, vaginal and fecal (24).
The first phase of this study also focused on prokaryotic diversity; all of the forensically
relevant body fluids were sampled, which included blood, saliva, urine, feces, semen, menstrual
fluid, and vaginal fluid. Bacterial signatures were developed for all of the fluids, though the
female intimate samples (vaginal fluid and menstrual blood) and semen could not be statistically
differentiated from each other, as seen in the Dobay et. al. study (23). Additional analyses
included limit of detection and mixture studies.
Project Goals
Now that signatures are being developed for the prokaryotic microbiome, the next step is
the examination of the eukaryotic microbes of the human body. The eukaryotic signature could
provide a greater specificity and statistical weight when discerning between body fluids. The
goal of this study is to sequence the V9 hypervariable region of the 18S rRNA gene in saliva,
feces and urine in order to identify the eukaryotic taxa present in each body fluid and compare
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the microbial communities of each fluid for the development of a statistical model for body fluid
identification.
Materials and Methods
Sample Collection and DNA Extraction
All samples were collected for previous research, following a VCU approved IRB
protocol (HM20002931). Saliva and feces samples were collected on sterile cotton swabs and
stored at room temperature in swab boxes. About half of each swab was used for extraction.
Liquid urine samples were stored at -80°C and 1ml of sample was used for extraction. Both the
fecal (n=72) and saliva (n=77) samples were extracted using Qiagen’s QIAamp® DNA
Investigator Kit (Hilden, Germany) on the Qiagen QIAcube® (Hilden, Germany). The samples
were eluted in 50µl for feces and 30µl for saliva. The urine (n=100) samples were extracted
using the QIAamp® DNA Micro Kit (Qiagen, Hilden, Germany) also on the QIAcube® and
eluted into 20µl. Due to sequencing space and barcoding constraints, the number of analysed
samples for each body fluid differed (Table 1). To ensure consistency and reliability throughout
the process, associated extraction reagent blanks and mock communities were analysed and
sequenced alongside the serological samples. The male and female urine samples were analysed
separately to remain consistent with the 16S bacterial phase of this study.
Bacterial DNA Quantification
All samples were quantified using the Applied Biosystems QuantStudio™ Flex Real-Time PCR
System and Software v1.3 (Thermo Fisher Scientific, Waltham, MA) using protocol as described
in Seashols-Williams et al. (2018). The ZymoBIOMICSTM Microbial Community DNA Standard
(Zymo Research Corp, Irvine, CA) was used as the mock community (positive control) for this
study.
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18S rDNA Amplification
The target region for eukaryote DNA identification was the hypervariable region V9 of
the 18S rRNA gene. The samples were barcoded then amplified on the Applied Biosystems
VeritiTM 96-Well Thermal Cycler (Thermo Fisher Scientific, Waltham, MA) using the primers
and an adapted protocol described by the Earth Microbiome Project
(http://press.igsb.anl.gov/earthmicrobiome/protocols-and-standards/18s/) as well as the dualindex strategy described by Kozich et al. (25). Each primer set consists of an Illumina® adapter
sequence so the DNA can attach to the MiSeq® flow cell, an eight nucleotide index sequence and
a ten nucleotide pad/linker sequence to increase the melting temperature, a two nucleotide noncomplementary linker sequence (CG for forward primer and CA for reverse primer), and a 18S
rRNA gene specific forward primer (V8_1391f: 5’- GTACACACCGCCCGTC -3’) and reverse
primer (V9_EukBr: 5’- TGATCCTTCTGCAGGTTCACCTAC -3’) (18, 26). To prevent the
host’s DNA from being amplified, mammalian blocking primer (Mammal_block_I-short_1391f)
was used in an 8:1 ratio of blocking primer to forward/reverse primer for the master mix. The
master mix included 12.5 µl of Promega 2X PCR master mix (Promega, Madison, WI), 1 µl (5
pmol/µl) each of forward and reverse primers, and 4 µl (10 pmol/µl) of mammalian blocking
primer. The amount of DNA added to each well in 1 µl was dependant on body fluid; 0.3 ng was
added for saliva and feces, while 0.02 ng was added for both male and female urine. These inputs
were based on the initial 16S bacterial phase of this study using the bacterial qPCR
quantification results (27). Nuclease free water was added to give a final total volume of 25 µl.
Gel Extraction and PCR Purification
After amplification, the samples were run on a 1.6% agarose gel using 3µl of PCR
product to make sure the amplified DNA was of the expected size. If a sample yielded more than
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one PCR product, the target band of 260bp was excised and the DNA purified from the gel using
the QIAquick® Gel Extraction Kit (Qiagen, Hilden, Germany) according to the manufacturer’s
protocol, with the remaining 22µl of PCR product and eluted at 50µl (28). All saliva and feces
samples required gel extraction while the urine samples did not. All amplified PCR products
were cleaned using the Agencourt® AMPure® PCR Purification Kit (Beckman Coulter, Brea,
CA) according to the manufacturer’s protocol using 10µl of PCR product for the urine samples
or gel extracted product for the saliva and feces samples and eluted in 35µl of elution buffer (29).
After purification, the samples were quantified using the Qubit™ dsDNA HS Assay Kit on the
Qubit® Fluorometer.
MiSeq® Sequencing
All clean, amplified 18S rRNA gene products were pooled in an equimolar concentration
of 1ng/µl. Average inputs were used for reagent blanks and negatives; i.e. if the average input for
the feces samples was 2µl, the associated reagent blanks and negative controls would be added to
the pool at that volume. The completed library pool was then sequenced on the MiSeq FGX
sequencing platform (Illumina Inc., USA) using the MiSeq 2X250 Reagent Kit v2 (Illumina Inc.,
USA) following the manufacturer’s protocol. There were two sequencing runs for this study,
including 41 reagent blanks, 2 mock communities, 5 PCR negatives, and a total of 249 body
fluid samples.
Data Analysis
The sequence data was analysed in Mothur (v1.39.5), an open source data analysis
program (30). A contig file was created to pair the forward and reverse reads and the sequences
were then aligned using the SILVA NR v132 reference database. The UCHIME program in
Mothur was used to isolate and remove chimera and singleton sequences. A read threshold of

12

200 reads was set as a baseline; if a sample contained 200 reads or less, it was removed from
analysis. The samples were classified and any unwanted taxa were removed to leave only the
eukaryotes. This removal included Archaea, Bacteria, Vertebrata, which includes Mammalia
(the host), and unknown or unclassified sequences. The family Aspergillaceae (Level 5), was
found to be common in reagent blanks across all body fluids and was also removed. It was
concluded that the reagent blank sequences were due to Aspergillaceae and not contamination.
The taxonomy file was used to construct a relative abundance chart at the family level (Level 5).
Taxa that contained less than 100 reads across all body fluids were grouped together as “Rare”
taxa. The Log10 of the relative abundance values was used to construct a heat map. Values of 0
were changed to 0.001 for logarithmic transformation. The distribution of highly abundant taxa
was used to determine possible predictor taxa for each body fluid. Alpha (α) and beta (β)
diversity measurements were assessed in Mothur using operational taxonomic units (OTUs) and
phylogenetic approaches. Alpha diversity was evaluated using OTUs at a 5% genetic distance.
Beta diversity was tested using analysis of molecular variance (AMOVA), to determine
significant differences between fluids, and visualized using principal coordinate analysis (PCoA)
using weighted UniFrac distances. PCoA and heat map data were plotted using the ggplot2
package in RStudio v3.6.3 (31).
Results
After lineage removal of the host sequences (i.e. vertebrates) and unclassified sequences
and after classification, the total number of samples dropped from 249 to 148 samples with a
read count above the threshold. This accounted for a 21% loss in feces samples, a 61% overall
loss in urine samples, and a 32.5% loss in saliva samples. The total number of reads for all
samples after sequence clean-up was 841,875 reads. There was a large variation in the read count
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across samples, ranging from 41,113 to 201 reads, with an overall average of 5,688 reads. Saliva
and urine experienced an 87% and 84% loss in sequence reads, respectively, while feces had a
49% loss in reads after sequence clean-up (Table 2).
The two mock communities, with 0.3ng and 0.02ng of DNA input, respectively, were
expected to contain the yeast species Saccharomyces cerevisiae and Cryptococcus neoformans.
Both mock communities contained the expected sequences and classified at the family level
(Figure 1). After removal of Aspergilaceae and classification, five out of forty-one reagent
blanks had read counts above threshold, all belonging to urine (Figure 2). The variety and
relative abundance of taxa within the reagent blanks was similar to the profiles of the urine
samples, indicating possible contamination. Thirteen associated urine samples were removed
from analysis, contributing 11% to the overall percent loss of urine samples.
General Sequence Characteristics
The total 841,875 sequences were classified into 27 phyla (Level 2), 53 classes
(Level 3), 105 orders (Level 4), 138 families (Level 5), and 205 genera. At all levels, 1.86% of
all reads were unclassified and could only be identified as eukaryote. It is important to note here
that 2% of all reads classified as Incertae Sedis, which is Latin for “uncertain placement”. It is a
taxonomic group that is essentially a placeholder for taxa whose broader relationships are
unknown or not yet defined (32).
Taxonomic Distribution of Sequences
At the family level (Level 5), the most abundant classified reads were different in taxa
and relative abundance for each body fluid (Figures 3 and 4). For feces, the most abundant taxa
were Saccharomycetaceae (80.1%), Malasseziaceae (3.2%), Incertae Sedis (3.1%), Poales
(2.6%), and Caryophyllales (2.0%). The male and female urine samples shared the top two most
14

abundant taxa but differed afterwards. The male urine was comprised of Malasseziaceae
(37.4%), Diptera (22.6%), Poales (9.7%), Saccharomycetaceae (4.1%), and Incertae Sedis
(3.7%), while the most abundant taxa in female urine were Malasseziaceae (36.6%), Diptera
(19.4%), Debaryomycetaceae (12.1%), Trichosporonaceae (7.0%), and Mucoraceae (5.4%). For
saliva, Poales (43.3%), Asparagales (10.3%), Saccharomycetaceae (8.9%), Chromulinales
(7.8%), and Debaryomycetaceae (7.6%) had the highest relative abundance. For further
visualization purposes, a heat map was created to indicate possible predictor taxa for each body
fluid at the family level (Level 5). Relative abundance was Log10 transformed and all taxa with
0% relative abundance were changed to 0.001 for logarithmic transformation. Possible indicator
taxa include Saccharomycetaceae for feces, Malasseziaceae and Diptera for urine, and Poales
and Asparagales for saliva.
Eukaryotic Diversity Measurements
The Inverse Simpson Index was used as a measure for α-diversity associated with each
body fluid (Figure 5). The index values begin at 1, indicating only a single species, and range to
a value that would indicate perfect evenness and be equal to the number of present taxa. The
average index values for each body fluid were 1.37 for feces, 2.42 for male urine, 1.54 for female
urine, and 1.70 for saliva. Male urine showed the greatest amount of species richness and feces
the least.
Analysis of molecular variance (AMOVA) based on weighted UniFrac distances (βdiversity) indicated significant differences in eukaryotic community structure between all body
fluid types, except male and female urine samples (Table 2).
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A two-dimensional principal coordinate analysis (PCoA) plot based on weighted UniFrac
distances explained 3.18% of variation associated with this data set and showed some clustering
of samples for each body fluid group; however distinct clustering and separation between
different fluid samples was not observed (Figure 6).
Discussion
This study utilized MiSeq sequencing of 18S rDNA to analyse the eukaryotic community
structure of feces, urine and saliva. A high quantity of mammalian blocking primer, which is a
species-specific oligonucleotide with a 3’ modification to prevent elongation of the host DNA
during PCR amplification, was used to prevent host DNA amplification (33). However, it did not
inhibit all host DNA amplification and in most samples a majority of the sequences were
classified as class Mammalia which resulted in a 41% sample loss. This was demonstrated
particularly in the urine samples, where there was an overall 61% loss in those samples after
sequence clean-up, indicating that there may be more human DNA from potential sources such
as skin cells than other eukaryotic DNA in that fluid. Percent sample loss in the remaining fluids
was about half or less than half that of the urine samples, suggesting that there was less host
DNA amplified in saliva and feces.
Another potential contributor to the greater loss of urine samples was the original DNA
input of 0.02ng for both male and female samples. This input was carried over from the 16S
bacterial phase of this study and based on bacterial quantitation (27). However, due to the
relatively reduced presence of eukaryotes versus bacteria in the human microbiome, the low
input of 0.02ng compared to the 0.3ng input used for saliva and feces could have prevented
amplification of eukaryotic DNA other than that of the host.
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Additionally, as the samples were processed, there was a continual dilution of the PCR
product from amplification to gel extraction, purification and sequencing. If the sample had a
reduced eukaryotic community from the start, some of those sequences may have been lost with
each step as the sample was diluted.
Taxonomic Diversity of Body Fluids
The alpha diversity, or species richness, of feces and female urine were less than that of
saliva and male urine, though male urine was the only fluid to have a significantly higher
average species richness (Figure 5). When compared to the alpha diversity of the prokaryotic
microbiome in these fluids, there was more species richness of bacteria in feces and saliva than
eukaryotes, but less richness of bacteria than eukaryotes in urine (27). This indicates that
possible eukaryotic indicator taxa for urine may be of more assistance in distinguishing body
fluids in conjunction with bacterial signatures than those of feces and saliva.
Both saliva and urine had more variation in eukaryotic taxa than feces, though each fluid
shared at least one taxon in the top most abundant eukaryotes. As all of the studied fluids are a
part of the digestive process, it stands to reason that they would all contain some common taxa
between them, as demonstrated by the overlap of different body fluid samples in the PCoA plot
(Figure 6). Saccharomycetaceae, a yeast family, was the most abundant in feces, but was also
present at lower levels in both saliva and urine. Also known as “sugar fungus” or “brewer’s
yeast”, these yeasts are very important for food production and fermentation and have been
previously identified as part of the human gut microbiome (34). They are likely abundant in
feces to assist with the decomposition of waste. Poales, another shared taxon, was the most
prevalent in saliva and is a large order of flowering plants that includes grass families, such as
rice, wheat and grain, and other plants such as flowering fruits (35). In addition, the second most
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abundant taxa in saliva and more unique to the fluid is also an order of plants: Asparagales,
whose taxa are more related by genetic sequence than by morphological structure. It is
unsurprising that plant material, which makes up the majority of the food that humans consume,
would be found in high abundance in the fluid that aids in breaking down food for digestion. In
both male and female urine, Malasseziaceae, a fungal family, was the most abundant taxa,
though it is shared between body fluids. Malassezia are yeast-like fungi known to be common on
human skin that are sustained by fatty acids and can cause skin disease (36). The second most
prevalent taxon in urine was Diptera, which is an order of flies. This was an unusual result and
there is nothing in the current literature to suggest why this occurred so abundantly across urine
samples or even in smaller amounts the other fluids.
All three fluids were found to be statistically significantly different from one another by
AMOVA pair-wise comparison, with the exception of male and female urine. Unlike their
bacterial 16S rDNA counterparts, male and female urine cannot be distinguished from each other
by their eukaryotic communities, even though the variety of taxa within male urine was
significantly higher than that of the female urine.
Possible Predictor Taxa
After studying the relative abundance chart of each body fluid at the family level (Level
5), it appeared as though each fluid has its own eukaryotic microbial signature (Figures 3 and
4). When choosing taxa that might distinguish one fluid from another, it was important to choose
taxa that were the most abundant and unique to the particular body fluid. Saccharomycetaceae
was selected as the indicator taxa for feces, as it was notably more abundant than any other taxon
in that fluid. Malasseziaceae and Diptera were chosen for urine because their combined
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abundance was unique to that fluid. Poales, for its abundance, and Asparagales, for its
uniqueness, were chosen as indicators for saliva.
Conclusion
Overall, the significant differences found between feces, urine and saliva indicate that
their eukaryotic characterization could be a useful complement to the previously developed
bacterial signatures for body fluid identification. These results can be further applied by studying
the effects of diluted, compromised or mixed fluid forensic samples on the species diversity
found in each fluid. This is a novel step forward in understanding the human eukaryotic
microbiome, but the general knowledge in this area is lacking in the scientific community. While
the bacterial microbiome has been thoroughly reviewed, more research is needed to better
understand and classify eukaryotes so that results produced from studies such as this are refined
with greater accuracy. The ultimate purpose of this research is to develop a confirmatory assay
combining both the bacterial and eukaryotic microbiomes for body fluid identification that works
in tandem with other DNA based methods.
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Figures and Tables
Table 1. Summary of analysed samples with demographic data.
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Table 2. Summary of the ranges and averages sequence reads for each body fluid before and
after quality control measures, i.e., after removal of sequences belonging to host (vertebrate).
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Table 3. P values of pair-wise AMOVA comparisons of each body fluid based on weighted
UniFrac distances. Experiment-wise error rate = 0.05 and pair-wise error rate (Bonferroni) =
0.00833333. Yellow indicates there is a significant difference between body fluids and blue
indicates no significant difference.

Saliva
Urine Female
Urine Male

Feces
0.00002*
0.00002*
0.00002*

Saliva

Urine Female

0.00002*
0.00002*

0.05074

*Indicates significance; Bonferroni pair-wise error rate: 0.00833333
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100%
98%

Relative Abundance

96%
94%
92%
90%

Cryptococcaceae

88%

Saccharomycetaceae

86%
84%
82%
80%
Mock 1 (0.3ng)

Mock 2 (0.02ng)

Mock Communities

Figure 1. Relative abundance of taxa at the family level in two mock communities (positive
controls).
Each mock community represented the two different sample DNA input amounts of 0.3ng and
0.02ng respectively. Both controls contained the expected yeast taxa.
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Mortierellaceae
Exidiaceae
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Relative Abundance

Pichiaceae
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Rhabditida_fa
Incertae_Sedis
Sporidiobolaceae

60

Asparagales_fa
Trichosporonaceae
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Debaryomycetaceae
Incertae_Sedis_fa
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Malasseziaceae

Poales_fa
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UrRB9

UrRB3

UrRB1

Urine Reagent Blanks

UrRB10

UrRB5

Diptera_fa
Saccharomycetaceae

Figure 2. Relative abundance of taxa at the family level in urine reagent blanks.
These five reagent blanks contained sequences after quality control measures (i.e. host sequence
and Aspergillaceae removal). Read counts ranged from 561 to 35,046 reads. The wide variety
and relative abundance of taxa in each were similar to the profile of the urine samples. Only the
top 15 most abundant taxa were included in this depiction.
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Relative Abundance of Taxa in Feces, Urine, and Saliva
Feces

Urine Male

Urine Female

Saliva

100%

Fabales_fa

90%

Caryophyllales_fa
Chromulinales_fa

80%

Incertae_Sedis
Relative Abundance

70%

Phaffomycetaceae
Pichiaceae

60%

Trichosporonaceae
Eukaryota_unclassified

50%

Incertae_Sedis_fa
40%

Asparagales_fa

Malasseziaceae

30%

Debaryomycetaceae
Diptera_fa

20%

Poales_fa
10%

Saccharomycetaceae

0%

Figure 3. Relative abundance of classified eukaryotes at family level (level 5).
Only the top fifteen most abundant taxa for all body fluids were included in this depiction.
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Figure 4. Relative abundance of the most abundant classified eukaryotes at family level (level 5).
For feces, the most abundant taxa is Saccharomycetaceae (80.1%). The male and female urine
samples share the top two most abundant taxa, Malasseziaceae (37.4% male, 36.6% female) and
Diptera (22.6% male, 19.4% female). For saliva, Poales (43.3%) and Asparagales (10.3%) have
the highest relative abundance.
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Figure 5. Inverse Simpson Index body fluid comparisons.
Alpha diversity of the eukaryotic communities within each body fluid. The black bar within each
box denotes the mean (average) index value for that fluid.
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Figure 6. Principle coordinate analysis using weighted Unifrac distances
Beta diversity of the eukaryote communities for each body fluid. The first two axes explain
2.04% and 1.14% of the variation in the original dissimilarity matrix, respectively. There is slight
clustering of each body fluid group; however they do not make distinct clusters.
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APPENDIX I
Mothur Commands & Options
Curation & Classification:
make.contigs(file=18S_BfID.txt,trimoverlap=t,insert=30, processors=4)
summary.seqs(fasta=18S_BfID.trim.contigs.fasta)
screen.seqs(fasta=18S_BfID.trim.contigs.fasta,group=18S_BfID.contigs.g
roups, maxambig=0, minlength=50, maxlength=200)
summary.seqs(fasta=18S_BfID.trim.contigs.good.fasta)
unique.seqs(fasta=18S_BfID.trim.contigs.good.fasta)
summary.seqs(fasta=18S_BfID.trim.contigs.good.unique.fasta,
name=18S_BfID.trim.contigs.good.names)
align.seqs(fasta=18S_BfID.trim.contigs.good.unique.fasta,
reference=silva.nr_v132.align, processors=4)
summary.seqs(fasta=18S_BfID.trim.contigs.good.unique.align,
name=18S_BfID.trim.contigs.good.names)
screen.seqs(fasta=18S_BfID.trim.contigs.good.unique.align,
name=18S_BfID.trim.contigs.good.names,
group=18S_BfID.contigs.good.groups,
summary=18S_BfID.trim.contigs.good.unique.summary,start=42554,end=4311
6, maxhomop=8)
summary.seqs(fasta=18S_BfID.trim.contigs.good.unique.good.align,
name=18S_BfID.trim.contigs.good.good.names)
filter.seqs(fasta=18S_BfID.trim.contigs.good.unique.good.align,
vertical=T, trump=.)
unique.seqs(fasta=18S_BfID.trim.contigs.good.unique.good.filter.fasta,
name=18S_BfID.trim.contigs.good.good.names)
summary.seqs(fasta=18S_BfID.trim.contigs.good.unique.good.filter.uniqu
e.fasta, name=18S_BfID.trim.contigs.good.unique.good.filter.names)
pre.cluster(fasta=18S_BfID.trim.contigs.good.unique.good.filter.unique
.fasta, name=18S_BfID.trim.contigs.good.unique.good.filter.names,
group=18S_BfID.contigs.good.good.groups, diffs=1)
summary.seqs(fasta=18S_BfID.trim.contigs.good.unique.good.filter.uniqu
e.precluster.fasta,
name=18S_BfID.trim.contigs.good.unique.good.filter.unique.precluster.n
ames)
chimera.uchime(fasta=18S_BfID.trim.contigs.good.unique.good.filter.uni
que.precluster.fasta,
name=18S_BfID.trim.contigs.good.unique.good.filter.unique.precluster.n
ames, group=18S_BfID.contigs.good.good.groups, dereplicate=t)
remove.seqs(fasta=18S_BfID.trim.contigs.good.unique.good.filter.unique
.precluster.fasta,
accnos=18S_BfID.trim.contigs.good.unique.good.filter.unique.precluster
.denovo.uchime.accnos,
name=18S_BfID.trim.contigs.good.unique.good.filter.unique.precluster.n
ames, group=18S_BfID.contigs.good.good.groups, dups=T)
summary.seqs(fasta=18S_BfID.trim.contigs.good.unique.good.filter.uniqu
e.precluster.pick.fasta,
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name=18S_BfID.trim.contigs.good.unique.good.filter.unique.precluster.p
ick.names)
*File names were shortened from this point forward
count.groups(group=18S_BfID.pick.groups)
get.groups(fasta=18S_BfID.pick.fasta, name=18S_BfID.pick.names,
group=18S_BfID.pick.groups, accnos=reducedfluids)
count.groups()
classify.seqs(fasta=18S_BfID.pick.pick.fasta,name=18S_BfID.pick.pick.n
ames,group=18S_BfID.pick.pick.groups,template=silva.nr_v132.align,
taxonomy=silva.nr_v132.tax, cutoff=80, processors=4)
remove.lineage(fasta=18S_BfID.pick.pick.fasta,name=18S_BfID.pick.pick.
names,group=18S_BfID.pick.pick.groups,taxonomy=18S_BfID.pick.pick.nr_v
132.wang.taxonomy,taxon=Chloroplast-Mitochondria-unknown-ArchaeaBacteria-unclassified-uncultured-Vertebrata-Aspergillaceae)
count.groups(group=18S_BfID.pick.pick.pick.groups)
get.groups(fasta=18S_BfID.pick.pick.pick.fasta,name=18S_BfID.pick.pick
.pick.names,group=18S_BfID.pick.pick.pick.groups,taxonomy=18S_BfID.pic
k.pick.nr_v132.wang.pick.taxonomy, accnos=reducedfluids2.txt)
classify.seqs(fasta=18S_BfID.pick.pick.pick.pick.fasta,name=18S_BfID.p
ick.pick.pick.pick.names,group=18S_BfID.pick.pick.pick.pick.groups,
template=silva.nr_v132.align,taxonomy=silva.nr_v132.tax,cutoff=80,
processors=6)
count.groups(group=18S_BfID.pick.pick.pick.pick.groups)
dist.seqs(fasta=18S_BfID.pick.pick.pick.pick.fasta,cutoff=0.20,
countends=F)
cluster(column=18S_BfID.pick.pick.pick.pick.dist,
name=18S_BfID.pick.pick.pick.pick.names, method=opti, cutoff=0.20)
make.shared(list=18S_BfID.pick.pick.pick.pick.opti_mcc.list,
group=18S_BfID.pick.pick.pick.pick.groups, label=0.05)
classify.otu(list=18S_BfID.pick.pick.pick.pick.opti_mcc.list,
name=18S_BfID.pick.pick.pick.pick.names,taxonomy=18S_BfID.pick.pick.pi
ck.pick.nr_v132.wang.taxonomy,label=0.05)
-diversity measurements:
collect.single(shared=18S_BfID.pick.pick.pick.pick.opti_mcc.shared,
calc=chao-ace-invsimpson-shannon-shannoneven, freq=10)
rarefaction.single(shared=18S_BfID.pick.pick.pick.pick.opti_mcc.shared
, calc=sobs, freq=10)
summary.single(calc=nseqs-coverage-sobs-invsimpson-shannonshannoneven, iters=1000)
Construct Phylogenetic Trees (-diversity):
dist.seqs(fasta=18S_BfID.pick.pick.pick.pick.fasta, output=phylip)
clearcut(phylip=18S_BfID.pick.pick.pick.pick.phylip.dist)
phylo.diversity(tree=18S_BfID.pick.pick.pick.pick.phylip.tre,
name=18S_BfID.pick.pick.pick.pick.names,group=18S_BfID.pick.pick.pick.pick
.groups, rarefy=T, freq=100)

36

//UniFrac unweighted//
unifrac.unweighted(tree=18S_BfID.pick.pick.pick.pick.phylip.tre,name=18S_B
fID.pick.pick.pick.pick.names,group=18S_BfID.pick.pick.pick.pick.groups,
distance=lt, random=F)
tree.shared(phylip=18S_BfID.pick.pick.pick.pick.phylip.tre1.unweighted.phy
lip.dist)
//UniFrac weighted//
unifrac.weighted(tree=18S_BfID.pick.pick.pick.pick.phylip.tre,
name=18S_BfID.pick.pick.pick.pick.names,group=18S_BfID.pick.pick.pick.pick
.groups, distance=lt, random=F)
tree.shared(phylip=18S_BfID.pick.pick.pick.pick.phylip.tre1.weighted.phyli
p.dist)
Tests for (-diversity):
amova(phylip=18S_BfID.pick.pick.pick.pick.phylip.tre1.weighted.phylip.dist
, design=AD_design_file.design, sets=all, iters=50000)
pcoa(phylip=18S_BfID.pick.pick.pick.pick.phylip.tre1.weighted.phylip.dist)
nmds(phylip=18S_BfID.pick.pick.pick.pick.phylip.tre1.weighted.phylip.dist,
mindim=3, maxdim=3, iters=5000)
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APPENDIX II
R Commands & Options
2-Dimensional PCOA:
pcoaw<-read.csv(file.choose(),header=TRUE)
require(ggplot2)
ggplot()+geom_point(aes(x=axis1,y=axis2,col=Body_Fluids),size=3,data=p
coaw) + xlab("Axis 1 (2.04%)") + ylab("Axis 2 (1.14%)") + theme() +
theme(axis.line = element_line(colour = "black"),panel.grid.minor =
element_blank(),panel.grid.major = element_blank())
Heat Map:
dlevel5<-read.csv(file.choose(),header=TRUE)
library(gplots)
library("RColorBrewer")
row.names (dlevel5) = dlevel5$taxon
dlevel5= dlevel5 [2:149]
dlevel5_matrix = data.matrix (dlevel5)
heatmap.2 (dlevel5_matrix,Rowv=FALSE, Colv=FALSE,
scale="none",cexRow=0.5,cexCol=0.3,margins=c(8,12), key=TRUE,
keysize= 1.0, symkey=FALSE, trace="none",, density.info="none",
col=brewer.pal(9,"YlGnBu"))
heatmap.2 (dlevel5_matrix,Rowv=TRUE, Colv=FALSE,
scale="none",cexRow=0.5,cexCol=0.3,margins=c(8,12), key=TRUE,
keysize= 1.0, symkey=FALSE, trace="none",, density.info="none",
col=brewer.pal(9,"YlGnBu"))
Inverse Simpson Boxplot:
alpha<-read.csv(file.choose(),header=TRUE)
head(alpha)
bf<-(alpha$Body_Fluid)
is<-(alpha$invsimpson)
boxplot(is~bf, main="Alpha Diversity",xlab="Body Fluids",ylab="Inverse
Simpson Index",col=c("purple","lightblue","yellow","gold"))
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